No Data
TIAN AN: Annual Report 2024
Guangdong Tianan New Material (603725.SH): intends to use no more than 0.4 billion yuan of idle own funds for Cash / Money Market management.
Gelonghui, April 16 - Guangdong Tianan New Material (603725.SH) announced that the company plans to use idle self-owned funds for Cash / Money Market management, with a total amount not exceeding 400 million yuan, and the funds can be used on a rolling basis within this limit.
Guangdong Tianan New Material (603725.SH): In 2024, net income is expected to decrease by 16.49% year-on-year, proposing a dividend of 1 yuan per 10 shares.
Gelonghui, April 16th丨Guangdong Tianan New Material (603725.SH) announced its 2024 annual report. During the reporting period, the company achieved revenue of 3,100.3037 million yuan, a year-on-year decrease of 1.32%; the net income attributable to the shareholders of the listed company was 101.0049 million yuan, a year-on-year decrease of 16.49%; the net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 90.4933 million yuan, a year-on-year increase of 23.40%. A cash dividend of 1 yuan per 10 shares will be distributed to all shareholders.
Tian An Australia Limited Releases 2024 Annual Report
TIANAN MEDICARE (00383.HK) spent 0.156 million HKD to repurchase 0.2 million shares on April 9.
Gelonghui reported on April 9 that TIANAN MEDICARE (00383.HK) announced the repurchase of 0.2 million shares on April 9, 2025, at a cost of 0.156 million HKD, with a repurchase price of 0.78 HKD per share.
TIANAN MEDICARE (00383) spent 0.156 million HKD on April 7 to repurchase 0.2 million shares.
TIANAN MEDICARE (00383) announced that it will spend 0.156 million Hong Kong dollars to buy back 0.2 million shares on April 7, 2025...
Not Many Are Piling Into Tian An China Investments Company Limited (HKG:28) Just Yet
